Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
94.75%
-
Total 13F principal
-
$212,916,019
-
Principal change
-
-$10,974,000
-
Total reported market value
-
$201,745,018
-
Number of holders
-
29
-
Value change
-
-$10,003,705
-
Number of buys
-
12
-
Number of sells
-
13
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q2 2016
As of 30 Jun 2016,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
29 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$212,916,019
in principal (par value) of the bond.
The largest 10 bondholders included
UBS ASSET MANAGEMENT AMERICAS INC, ASCEND CAPITAL, LLC, WHITEBOX ADVISORS LLC, CNH PARTNERS LLC, SANDERS MORRIS HARRIS INC., PIONEER INVESTMENT MANAGEMENT INC, OAKTREE CAPITAL MANAGEMENT LP, Park West Asset Management LLC, LAZARD ASSET MANAGEMENT LLC, and ZAZOVE ASSOCIATES LLC.
This page lists
29
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.